» Articles » PMID: 26001049

Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Enterobacteriaceae Isolated from Egyptian Patients with Suspected Blood Stream Infection

Overview
Journal PLoS One
Date 2015 May 23
PMID 26001049
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of the study was to investigate the prevalence of extended-spectrum β-lactamase and carbapenemase production among Enterobacteriaceae isolated from Egyptian patients with suspected blood stream infection.

Methods: Ninety-four Enterobacteriaceae blood culture isolates from Egyptian patients with suspected blood stream infection were collected, one isolate per patient. Identification of bacterial isolates was performed with MALDI-TOF (MS-based Vitek MS system, bioMerieux). Screening for ESBLs and carbapenemases production was done with the Vitek 2 system (bioMérieux). ESBL production was confirmed using the combined disk diffusion method for cefotaxime, ceftazidime, and cefepime, all with and without clavulanic acid (Rosco). Real-time PCR and sequencing were used to characterize the resistance genes. The phylogenetic groups of E. coli were identified by a PCR-based method.

Results: Of the 94 Enterobacteriaceae isolates 46 (48.93%) showed an ESBL phenotype. One Enterobacter spp isolate was ESBL-producer and meropenem-resistant. The genetic analysis showed that CTX-M was present in 89.13% (41/46) of the ESBL-producing Enterobacteriaceae, whereas TEM and SHV were detected in 56.52% (26/46) and 21.74% (10/46) respectively (47.83%) of the ESBL-producing isolates were multidrug resistant (MDR). Eleven out of 30 ESBL-producing E-coli isolates were assigned to phylogroup B2, followed by groups B1 (8 isolates), A (6 isolates) and D (5 isolates).

Conclusions: The high ESBL-E rates (48.93%) found in this study together with the identification of one carbapenem-resistant Enterobacter spp isolate is worrisome. Our results indicate that systems for monitoring and detection of ESBL-producing bacteria in Egyptian hospitals have to be established. Also strict hospital infection control policies with the restriction of the consumption of extended-spectrum cephalosporins are necessary.

Citing Articles

An exploration of the ocular mysteries linking nanoparticles to the patho-therapeutic effects against keratitis.

Qu S, Zheng S, Muhammad S, Huang L, Guo B J Nanobiotechnology. 2025; 23(1):184.

PMID: 40050881 PMC: 11887204. DOI: 10.1186/s12951-025-03230-3.


Investigation of methicillin, beta lactam, carbapenem, and multidrug resistant bacteria from blood cultures of septicemia suspected patients in Northwest Ethiopia.

Birhanu A, Gebre G, Getaneh E, Yohannes H, Baye N, Mersha G Sci Rep. 2025; 15(1):5769.

PMID: 39962179 PMC: 11833138. DOI: 10.1038/s41598-025-86648-x.


Molecular Assessment Using the MASTDISCS® Combi D72C Set for the Phenotypic Detection of Extended-Spectrum Beta-Lactamases, AmpC Beta-Lactamases, and Carbapenemase Enzymes in Escherichia coli and Klebsiella pneumoniae.

Haji S, Ganjo A, Abdulaziz S, Abdullah Z, Smail S Cureus. 2025; 17(1):e77269.

PMID: 39931609 PMC: 11808409. DOI: 10.7759/cureus.77269.


Prevalence and molecular characterization of ESBL-producing Enterobacteriaceae in Egypt: a systematic review and meta-analysis of hospital and community-acquired infections.

Azzam A, Khaled H, Samer D, Nageeb W Antimicrob Resist Infect Control. 2024; 13(1):145.

PMID: 39639352 PMC: 11622690. DOI: 10.1186/s13756-024-01497-z.


Predominance of enterotoxigenic Escherichia coli among ESBL/plasmid-mediated AmpC-producing strains isolated from diarrheic foals: a public health concern.

Samir A, Abdel-Moein K, Zaher H Acta Vet Scand. 2024; 66(1):54.

PMID: 39363309 PMC: 11448284. DOI: 10.1186/s13028-024-00774-6.


References
1.
Saied T, Elkholy A, Hafez S, Basim H, Wasfy M, El-Shoubary W . Antimicrobial resistance in pathogens causing nosocomial bloodstream infections in university hospitals in Egypt. Am J Infect Control. 2011; 39(9):e61-5. DOI: 10.1016/j.ajic.2011.04.009. View

2.
Carlet J, Pittet D . Access to antibiotics: a safety and equity challenge for the next decade. Antimicrob Resist Infect Control. 2013; 2(1):1. PMC: 3599140. DOI: 10.1186/2047-2994-2-1. View

3.
Tsakris A, Kristo I, Poulou A, Themeli-Digalaki K, Ikonomidis A, Petropoulou D . Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. J Clin Microbiol. 2008; 47(2):362-7. PMC: 2643660. DOI: 10.1128/JCM.01922-08. View

4.
Olesen I, Hasman H, Aarestrup F . Prevalence of beta-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark. Microb Drug Resist. 2005; 10(4):334-40. DOI: 10.1089/mdr.2004.10.334. View

5.
Canton R, Gonzalez-Alba J, Galan J . CTX-M Enzymes: Origin and Diffusion. Front Microbiol. 2012; 3:110. PMC: 3316993. DOI: 10.3389/fmicb.2012.00110. View